Covid-19 roundup: Mod­er­na show­cas­es progress on its bi­va­lent boost­er; No­vavax wins ap­proval in Japan

New da­ta from Mod­er­na of­fer en­cour­ag­ing re­sults for the mR­NA pow­er­house’s bi­va­lent boost­er can­di­date.

The bi­va­lent boost­er can­di­date, known as mR­NA-1273.211 and which in­cludes mu­ta­tions …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.